Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
8.92M
-
Shares change
-
-244K
-
Total reported value, excl. options
-
$157M
-
Value change
-
-$4.77M
-
Put/Call ratio
-
0.85
-
Number of buys
-
47
-
Number of sells
-
-76
-
Price
-
$17.62
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q4 2024
174 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q4 2024.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.92M shares
of 10.9M outstanding shares and own 81.75% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (919K shares), RENAISSANCE TECHNOLOGIES LLC (904K shares), VANGUARD GROUP INC (758K shares), GOLDMAN SACHS GROUP INC (353K shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (295K shares), D. E. Shaw & Co., Inc. (289K shares), MORGAN STANLEY (286K shares), FEDERATED HERMES, INC. (279K shares), BANK OF AMERICA CORP /DE/ (276K shares), and ACADIAN ASSET MANAGEMENT LLC (273K shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.